Lack of association between serum brain-derived neurotrophic factor levels and improvement of schizophrenia symptoms in a double-blind, randomized, placebo-controlled trial of memantine as adjunctive therapy to clozapine.

de Lucena, D; Fernandes, BS; Kunz, M; Fries, GR; Stertz, L; Aguiar, B; Pfaffenseller, B; Gama, CS

Lack of association between serum brain-derived neurotrophic factor levels and improvement of schizophrenia symptoms in a double-blind, randomized, placebo-controlled trial of memantine as adjunctive therapy to clozapine.

Version 2 2024-06-13, 09:33

Version 1 2016-10-20, 14:08

journal contribution

posted on 2024-06-13, 09:33 authored by D de Lucena, BS Fernandes, M Kunz, GR Fries, L Stertz, B Aguiar, B Pfaffenseller, CS Gama

Lack of association between serum brain-derived neurotrophic factor levels and improvement of schizophrenia symptoms in a double-blind, randomized, placebo-controlled trial of memantine as adjunctive therapy to clozapine.

History

Journal

The Journal of clinical psychiatry

Volume

71

Article number

1

Pagination

91-91

Publication classification

E3.1 Extract of paper

Publisher

Pergamon Press

Usage metrics

Keywords

Uncategorised value

Licence

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Lack of association between serum brain-derived neurotrophic factor levels and improvement of schizophrenia symptoms in a double-blind, randomized, placebo-controlled trial of memantine as adjunctive therapy to clozapine.

History

Journal

Volume

Article number

Pagination

Publication classification

Publisher

Usage metrics

Categories

Keywords

Licence

Exports